GLSI vs. ACXP
GLSI (Greenwich LifeSciences, Inc.) and ACXP (Acurx Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, GLSI returned -19.31%/yr vs -58.26%/yr for ACXP. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
GLSI vs. ACXP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLSI achieves a -35.74% return, which is significantly higher than ACXP's -42.17% return.
GLSI
- 1D
- -3.71%
- 1M
- -38.64%
- 6M
- -55.10%
- YTD
- -35.74%
- 1Y
- 21.73%
- 3Y*
- 10.93%
- 5Y*
- -19.31%
- 10Y*
- —
- ALL TIME*
- 15.72%
ACXP
- 1D
- 1.41%
- 1M
- -10.00%
- 6M
- -39.11%
- YTD
- -42.17%
- 1Y
- -76.55%
- 3Y*
- -66.87%
- 5Y*
- -58.26%
- 10Y*
- —
- ALL TIME*
- -57.93%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $106.69K | $141.74K | $162.46K | |
| $2.85M | $2.86M | $3.32M |
GLSI vs. ACXP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GLSI Greenwich LifeSciences, Inc. | -35.74% | 87.09% | 6.75% | -30.79% | -37.53% | -44.34% |
ACXP Acurx Pharmaceuticals, Inc. | -42.17% | -84.71% | -78.75% | -3.77% | -7.90% | -27.37% |
Correlation
The correlation between GLSI and ACXP is 0.20, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.20 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2021 | 0.17 |
Fundamentals
GLSI:
$198.16M
ACXP:
$2.28M
GLSI:
-$1.56
ACXP:
-$866.03
GLSI:
37.31
ACXP:
0.00
GLSI:
$3.56K
ACXP:
$0.00
GLSI:
$903.00
ACXP:
$0.00
GLSI:
-$21.89M
ACXP:
-$5.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLSI vs. ACXP — Risk / Return Rank
GLSI
ACXP
GLSI vs. ACXP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Greenwich LifeSciences, Inc. (GLSI) and Acurx Pharmaceuticals, Inc. (ACXP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLSI | ACXP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.66 | ||
| Sortino ratioReturn per unit of downside risk | +1.38 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 0.97 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | -0.94 | +1.32 |
| Martin ratioReturn relative to average drawdown | 0.89 | -1.29 | +2.19 |
Loading charts...
Drawdowns
GLSI vs. ACXP - Drawdown Comparison
The maximum GLSI drawdown since its inception was -90.11%, smaller than the maximum ACXP drawdown of -99.14%. Use the drawdown chart below to compare losses from any high point for GLSI and ACXP.
Loading charts...
Drawdown Indicators
| GLSI | ACXP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.11% | -99.14% | +9.03% |
Max Drawdown (1Y)Largest decline over 1 year | -61.87% | -83.33% | +21.46% |
Max Drawdown (3Y)Largest decline over 3 years | -61.87% | -98.83% | +36.96% |
Max Drawdown (5Y)Largest decline over 5 years | -84.52% | -98.84% | +14.32% |
Current DrawdownCurrent decline from peak | -81.31% | -99.09% | +17.78% |
Average DrawdownAverage peak-to-trough decline | -72.80% | -70.16% | -2.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.24% | 60.56% | -34.32% |
Volatility
GLSI vs. ACXP - Volatility Comparison
Greenwich LifeSciences, Inc. (GLSI) has a higher volatility of 29.58% compared to Acurx Pharmaceuticals, Inc. (ACXP) at 20.58%. This indicates that GLSI's price experiences larger fluctuations and is considered to be riskier than ACXP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLSI | ACXP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.58% | 20.58% | +9.00% |
Volatility (6M)Calculated over the trailing 6-month period | 69.03% | 120.16% | -51.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 98.53% | 185.91% | -87.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.02% | 139.94% | -59.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 422.94% | 139.84% | +283.10% |
Dividends
GLSI vs. ACXP - Dividend Comparison
Neither GLSI nor ACXP has paid dividends to shareholders.
Financials
GLSI vs. ACXP - Financials Comparison
This section allows you to compare key financial metrics between Greenwich LifeSciences, Inc. and Acurx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GLSI and ACXP have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLSI has higher volatility (29.58%) compared to ACXP (20.58%). In terms of maximum drawdown, GLSI dropped -90.11% vs ACXP's -99.14%.
GLSI currently has the higher Sharpe Ratio (0.24 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLSI and ACXP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer